About ::Dr. Mary Ann Drosnock::

Dr. Mary Ann Drosnock is the Director of Clinical Affairs at Healthmark Industries, where she provides expertise in medical device processing and infection prevention and leads an experienced team of Clinical Educators. For 9 years, she was co-chair of AAMI WG 84, which writes ST91, the national standard on flexible endoscope reprocessing, and TIR99 on the processing of ultrasound probes and dilators. Previous to Healthmark, Mary Ann managed the Infection Control Program for Olympus America, worked and managed labs as a pharmaceutical microbiologist, and taught Microbiology courses at the college level. MaryAnn has a B.S. in Biology, an M.S. in Quality and Regulatory Affairs, and a DrHSc in Healthcare Administration and Management. She is certified in Drug Development, Pharmaceutical Science, Infection Control, Flexible Endoscope Reprocessing, is a Nationally Certified Registered Microbiologist and is a fellow of both APIC and AAMI.